| Doreen B Kalter, MD | |
|
372 Washington St, Wellesley, MA 02481-6202 | |
| (781) 239-3550 | |
| (781) 239-3272 |
| Full Name | Doreen B Kalter |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 372 Washington St, Wellesley, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073525267 | NPI | - | NPPES |
| M09945 | Other | MA | BLUE CROSS OF MA |
| 043961 | Other | MA | TUFTS HEALTH PLAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 43961 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Doreen B Kalter, MD 372 Washington St, Wellesley, MA 02481-6202 Ph: (781) 239-3550 | Doreen B Kalter, MD 372 Washington St, Wellesley, MA 02481-6202 Ph: (781) 239-3550 |
News Archive
Ceridia Pty Ltd., a biotechnology company focused on reformulating and developing therapeutic drugs, announce the successful completion of Phase 1 Proof-of-Concept study of its novel LipoCeramic ibuprofen formulation, CER006.
St. John Hospital is among the first in the state and the only site in southeast Michigan to offer a new alternative treatment for patients with acid reflux disease.
Scientists uncover a port of liver entry for malaria parasites in a report published in The Journal of Experimental Medicine. If these results hold up in humans, drugs that target this entry protein might help prevent the spread of disease.
Southeast Pain Care, a division of Southeast Anesthesiology Consultants, is sponsoring the Dec. 3 performance of "Grease" at Ovens Auditorium and giving $10 for every ticket sold to the American Pain Foundation.
Alkermes plc today announced positive topline results from a randomized, double-blind, placebo-controlled phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia. Patients treated once monthly with either 441 mg or 882 mg of aripiprazole lauroxil demonstrated statistically significant reductions from baseline in Positive and Negative Syndrome Scale (PANSS) total scores at week 12, compared to placebo (p<0.001 aripiprazole lauroxil 441 mg, p<0.001 aripiprazole lauroxil 882 mg), which was the prespecified primary endpoint in the study. Based on the positive results from this phase 3 study, Alkermes plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the third quarter of 2014.
› Verified 6 days ago
Ekta Taneja, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 25 Walnut St Ste 300, Wellesley, MA 02481 Phone: 617-600-8823 | |
Nancy J Donovan, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 27 Mica Ln, Suite 106, Wellesley, MA 02481 Phone: 781-259-0050 | |
Dr. Susan Edith Ruskin, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 11 River St, Wellesley, MA 02481 Phone: 781-647-0496 | |
Priyamvada Kota, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Harvard Vanguard Medical Associates, 230 Worcester Street, Wellesley, MA 02481 Phone: 781-431-5270 Fax: 781-431-5535 | |
Shih Yee-marie Tan Gipson, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 18 Grove St # 6, Wellesley, MA 02482 Phone: 617-326-5102 | |
Alison C Phillips, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 27 Mica Ln, Suite 205, Wellesley, MA 02481 Phone: 781-237-2335 |